BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 969 filers reported holding BAXTER INTL INC in Q3 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $351,557 | -9.7% | 9,315 | +9.0% | 0.00% | 0.0% |
| Q2 2023 | $389,503 | +11.9% | 8,549 | -0.4% | 0.00% | 0.0% |
| Q1 2023 | $348,131 | -41.5% | 8,583 | -26.5% | 0.00% | -40.0% |
| Q4 2022 | $595,000 | +68.6% | 11,677 | +77.9% | 0.01% | +66.7% |
| Q3 2022 | $353,000 | -35.5% | 6,562 | -23.0% | 0.00% | -25.0% |
| Q2 2022 | $547,000 | -20.8% | 8,524 | -4.3% | 0.00% | -20.0% |
| Q1 2022 | $691,000 | -10.3% | 8,910 | -0.7% | 0.01% | 0.0% |
| Q4 2021 | $770,000 | -32.7% | 8,973 | -36.9% | 0.01% | -37.5% |
| Q3 2021 | $1,144,000 | +110.3% | 14,227 | +110.5% | 0.01% | +100.0% |
| Q2 2021 | $544,000 | -3.7% | 6,759 | +1.0% | 0.00% | -20.0% |
| Q1 2021 | $565,000 | -2.2% | 6,695 | -7.0% | 0.01% | -16.7% |
| Q4 2020 | $578,000 | +0.9% | 7,201 | +1.0% | 0.01% | 0.0% |
| Q3 2020 | $573,000 | -14.6% | 7,130 | -8.5% | 0.01% | -25.0% |
| Q2 2020 | $671,000 | +10.2% | 7,791 | +3.9% | 0.01% | -11.1% |
| Q1 2020 | $609,000 | -19.0% | 7,496 | -16.7% | 0.01% | +12.5% |
| Q4 2019 | $752,000 | +12.7% | 8,996 | +10.4% | 0.01% | 0.0% |
| Q3 2019 | $667,000 | 0.0% | 8,145 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $667,000 | -8.8% | 8,145 | -9.3% | 0.01% | -11.1% |
| Q1 2019 | $731,000 | +25.4% | 8,985 | +1.4% | 0.01% | +12.5% |
| Q4 2018 | $583,000 | -14.0% | 8,860 | +0.7% | 0.01% | 0.0% |
| Q3 2018 | $678,000 | 0.0% | 8,800 | -4.1% | 0.01% | 0.0% |
| Q2 2018 | $678,000 | -99.9% | 9,179 | +31.5% | 0.01% | +33.3% |
| Q1 2018 | $453,930,000 | +0.6% | 6,979 | 0.0% | 0.01% | +20.0% |
| Q4 2017 | $451,135,000 | +4.2% | 6,979 | +1.2% | 0.01% | 0.0% |
| Q3 2017 | $432,789,000 | -2.8% | 6,897 | -6.2% | 0.01% | -16.7% |
| Q2 2017 | $445,070,000 | +11.8% | 7,352 | -18.1% | 0.01% | 0.0% |
| Q1 2017 | $397,992,000 | +99647.4% | 8,975 | -0.3% | 0.01% | 0.0% |
| Q4 2016 | $399,000 | -99.9% | 9,000 | -8.5% | 0.01% | -14.3% |
| Q3 2016 | $468,412,000 | +5.0% | 9,841 | -0.2% | 0.01% | 0.0% |
| Q2 2016 | $445,971,000 | -40.5% | 9,862 | -45.9% | 0.01% | -41.7% |
| Q1 2016 | $749,054,000 | -24.0% | 18,234 | -29.4% | 0.01% | -25.0% |
| Q4 2015 | $984,999,000 | -51.5% | 25,819 | -58.2% | 0.02% | -52.9% |
| Q3 2015 | $2,031,084,000 | -95.3% | 61,829 | -90.1% | 0.03% | -95.0% |
| Q2 2015 | $43,586,736,000 | +1.2% | 623,290 | -0.8% | 0.68% | +2.1% |
| Q1 2015 | $43,052,597,000 | -8.9% | 628,505 | -2.6% | 0.66% | -13.2% |
| Q4 2014 | $47,273,632,000 | +1.4% | 645,022 | -0.7% | 0.76% | -6.3% |
| Q3 2014 | $46,630,443,000 | +2.4% | 649,721 | +3.2% | 0.81% | +5.2% |
| Q2 2014 | $45,533,747,000 | +5357.3% | 629,789 | +5453.7% | 0.77% | +5060.0% |
| Q1 2014 | $834,363,000 | +14.3% | 11,340 | +8.0% | 0.02% | +7.1% |
| Q4 2013 | $730,275,000 | +45.4% | 10,500 | +37.3% | 0.01% | +40.0% |
| Q3 2013 | $502,200,000 | +97.3% | 7,645 | +108.1% | 0.01% | +66.7% |
| Q2 2013 | $254,498,000 | – | 3,674 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |